The 75th annual meeting special lecture: Where do we stand with BCG vaccination programme in Japan?

Kekkaku

Volumn 76, Issue 4, 2001, Pages 385-397

  Mori, T ^a  

^a FUKUJUJI HOSPITAL   (Japan)

Author keywords

BCG vaccination; BCG vaccine; Epidemiology; Preventive medicine; Tuberculosis control

Indexed keywords

BCG VACCINATION; CONFERENCE PAPER; COST EFFECTIVENESS ANALYSIS; DRUG EFFICACY; HEALTH PROGRAM; IMMUNITY; JAPAN; TUBERCULOSIS CONTROL; TUBERCULOUS LYMPHADENITIS; ARTICLE; CHILD; HUMAN; IMMUNIZATION; INFANT; STANDARD; TUBERCULOSIS; VACCINATION;

BCG VACCINE;

BCG VACCINE; CHILD; HUMANS; IMMUNIZATION SCHEDULE; INFANT; JAPAN; TUBERCULOSIS; VACCINATION;

EID: 0035318196     PISSN: 00229776     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (41)

1. Impact of BCG vaccination programmes in children and young adults on the tuberculosis programme
2. Trial of BCG vaccine in South India for Tuberculosis Prevention
3. The role of BCG vaccines in the prevention and control of Tuberculosis in the United States, A joint statement by the advisory council for the elimination of Tuberculosis and the advisory Committee on Immunization practice
4. The efficacy of Bacillus Calmette-Guerin vaccination of newborns and infants in the prevention of tuberculosis: Meta-analysis of the published literature
5. Variation in protection by BCG: Implications of and for heterologous immunity
6. Some evidence of the efficacy of mass BCG vaccination
7. BCG vaccination policies according to the epidemiological situation
8. Anatomical and roentgenologic studies of tuberculosis infection in BCG-vaccinated and non-vaccinated subjects
9. The protective effect of BCG vaccination as indicated by autopsy studies
10. BCG and vole bacillus vaccines in the prevention of tuberculosis in adolescence and early adult life
11. Statement on BCG revaccination for the prevention of tuberculosis
12. The duration of BCG-induced tuberculin sensitivity in children, and its irrelevance for revaccination
13. The immunity conferred by effective BCG and vole bacillus vaccines, in relation to individual variations in induced tuberculin sensitivity and to technical variations in the vaccines
14. Does the efficacy of BCG decline with time since vaccination
15. The immediate effects of BCG revaccination
16. Revaccination with BCG vaccine. An experimental study with guinea pigs
17. Duration of allergy and immunity in BCG-vaccinated guinea-pigs
18. Randomized controlled trial of single BCG, repeated BCG, or combined BCG killed Mycobacterium leprae vaccine for prevention of leprosy tuberculosis Malawi
19. Efficacy of BCG vaccine against leprosy and tuberculosis in northern Malawi
20. Tuberculosis among non-BCG-revaccinated Finnish schoolchildren
21. Criteria for discontinuation of vaccination programmes using Bacille Calmette-Guerin (BCG) in countries with a low prevalence of tuberculosis. A statement of the International Union against Tuberculosis and Lung Disease
22. Childhood tuberculosis in Sweden. An epidemiological study made six years after the cessation of general BCG vaccination of the newborn
23. Evaluation of tuberculosis control policies using computer simulation
24. Lymph node swelling due to Calmette-Guerin vaccination with multipuncture method
25. Swedish experience 12 years general BCG vaccination of newbron in 1975
26. Practical consequences of estimating the risk of tuberculous infection on the policy making in Sweden
27. Progress in the development of new vaccines against tuberculosis